Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.42 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.42 |
| ▸ | FEN1 | P39748 | 1/20 | 0.42 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | HEXA | P06865 | 3/20 | 0.40 |
| ▸ | HEXB | P07686 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6346833 | 0.83 | HEXA (0.55) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL18485429 | 0.82 | TDP1 (0.55) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL13609715 | 0.81 | RXFP1 (0.61) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL18485418 | 0.81 | ALDH1A1 (0.56) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL6349229 | 0.80 | KDM4E (0.44) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL24756847 | 0.77 | KDM4E (0.52) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL24756852 | 0.77 | KDM4E (0.49) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL18485459 | 0.76 | FGFR1 (0.51) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL13898970 | 0.75 | KDM4E (0.57) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL24634086 | 0.75 | RAB9A (0.56) | KDM4EALDH1A1MEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1975160-B1 | Polymerizable compound, polymer, ink composition, printed articles and inkjet recording method | FUJIFILM CORP (JP) | 2013-01-16 | — | — | EP | disclosed |
| US-8173226-B2 | Polymerizable compound , polyethylene glycol mono(meth)acrylate, a polystyrene oligomer having a methacryloyl group at one terminal, acrylic macromonomer imides | FUJIFILM CORPORATION (JP) | 2012-05-08 | — | — | US | disclosed |
| US-20090214797-A1 | INKJET INK COMPOSITION, AND INKJET RECORDING METHOD AND PRINTED MATERIAL EMPLOYING SAME | FUJIFILM CORPORATION (JP) | 2009-08-27 | — | — | US | disclosed |
| US-20090214797-A1 | INKJET INK COMPOSITION, AND INKJET RECORDING METHOD AND PRINTED MATERIAL EMPLOYING SAME | FUJIFILM CORPORATION (JP) | 2009-08-27 | — | — | US | disclosed |
| US-20080241416-A1 | POLYMERIZABLE COMPOUND, POLYMER, INK COMPOSITION, PRINTED ARTICLES AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080241416-A1 | POLYMERIZABLE COMPOUND, POLYMER, INK COMPOSITION, PRINTED ARTICLES AND INKJET RECORDING METHOD | CNOT1, CCNT1, SCO2 | KDM4E 930/4885ALDH1A1 1750/4885MEN1 1046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.